Joseph E. Glass, PhD, MSW

Glass_Joseph_E_205x287.jpg

“We need to increase the reach of addiction treatment within health care systems. Many more people could benefit from effective care.”

Joseph E. Glass, PhD, MSW

Associate Investigator, Kaiser Permanente Washington Health Research Institute
Affiliate Associate Professor, Department of Health Systems and Population Health, Department of Psychiatry and Behavioral Sciences, University of Washington

Biography

Joseph Glass, PhD, MSW, is an associate investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin–Madison School of Social Work.

Dr. Glass’s research seeks to identify how effective health care interventions for unhealthy alcohol and drug use can reach more people. Much of his work aims to develop, test, and implement modern models of care that proactively deliver evidence-based treatments within health care settings and that intensively refer patients to specialty care while considering social determinants of health.

Dr. Glass’s work is informed by his practical experience in the field. After receiving a Master of Social Work from the University of Michigan, Dr. Glass was a psychiatric social worker at the Veterans Affairs Ann Arbor Healthcare System. There he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders.

He completed a 5-year career development award funded by the National Institute on Alcohol Abuse and Alcoholism in 2021, which allowed him to obtain intensive training in clinical trials and implementation science. Currently, he has 2 active randomized controlled trials.

  • One is a 5-year grant awarded by the National Institute on Drug Abuse called the DIGITS Trial, which is testing strategies for improving how clinicians and patients use app-based treatments for substance use disorder in primary care.
  • Another study is the Addressing Barriers to Care Trial (ABC-SUD), which is a 5-year grant awarded by the National Institute on Drug Abuse as part of the Center for Dissemination and Implementation Science at Stanford. The ABC-SUD study is evaluating use of Care Navigators to improve the rate at which people successfully obtain treatment when they are referred to care.

Dr. Glass also co-leads a 2-year study funded by the National Institute on Alcohol Abuse and Alcoholism to validate and improve approaches for monitoring the quality of care for alcohol use disorder. He also enjoys serving as a co-investigator and consultant, providing expertise and support to studies led by his colleagues.

Dr. Glass is an affiliate associate professor of health systems and population health, and of psychiatry and behavioral sciences, at the University of Washington.​​​​​

Research interests and experience


Sparc trial tools

Resources for behavioral health integration

The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.


Recent publications

Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, Braciszewski JM, Murphy MT, Dryden D, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Phillips RC, Shea M, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA; PROUD Trial Collaborators; Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. Nurse care management for opioid use disorder treatment: The PROUD cluster randomized clinical trial. JAMA Intern Med. 2023 Oct 30:e235701. doi: 10.1001/jamainternmed.2023.5701. [Epub ahead of print]. PubMed

Chen AT, Johnny S, Chaliparambil R, Wong S, Glass JE. Considering the role of information and context in promoting health-related behavioral change.  Proc Assoc Inf Sci Technol. 2023;60(1):908-910. doi: 10.1002/pra2.894. Epub 2023 Oct 22.  PubMed

Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. J Subst Use Addict Treat. 2023 Dec:155:209175. doi: 10.1016/j.josat.2023.209175. Epub 2023 Sep 24. PubMed

Mogk JM, Matson TE, Caldeiro RM, Garza Mcwethy AM, Beatty T, Sevey BC, Hsu CW, Glass JE. Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: A qualitative study. Addict Sci Clin Pract. 2023;18(1):27. doi: 10.1186/s13722-023-00387-w.  PubMed

Frost MC, Soyer EM, Achtmeyer CE, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Treating opioid use disorder in Veterans with co-occurring substance use: A qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Addict Sci Clin Pract. 2023;18(1):26. doi: 10.1186/s13722-023-00382-1.  PubMed

 

Healthy Findings Blog

ABC-Study_JoeGlass_QA_1col.jpg

Understanding the needs of people seeking care for substance use

Joe Glass explores how to engage patients with treatment for alcohol or drug use.

Research

PROUD_trial_1col.jpg

Increasing opioid use disorder treatment in primary care

A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.

Research

SPARC-study_story_blog_1col.jpg

Better care for patients who drink alcohol

A new primary care approach improves alcohol-related preventive care as well as care for alcohol use disorder.